Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-010217
Filing Date
2023-04-14
Accepted
2023-04-14 08:30:50
Documents
21

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A lmat20230405_def14a.htm   iXBRL DEF 14A 1172739
6 graph01.jpg GRAPHIC 28271
7 graph02.jpg GRAPHIC 30088
8 graph03.jpg GRAPHIC 31914
9 graph04.jpg GRAPHIC 27314
10 gwl01.jpg GRAPHIC 5191
11 jpp01.jpg GRAPHIC 3079
12 lmat01.jpg GRAPHIC 2678
  Complete submission text file 0001437749-23-010217.txt   2231389

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lmat-20221231.xsd EX-101.SCH 8349
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lmat-20221231_def.xml EX-101.DEF 10982
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20221231_lab.xml EX-101.LAB 22558
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20221231_pre.xml EX-101.PRE 11170
15 EXTRACTED XBRL INSTANCE DOCUMENT lmat20230405_def14a_htm.xml XML 168048
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33092 | Film No.: 23819841
SIC: 3841 Surgical & Medical Instruments & Apparatus